Longitudinal trends of recent HIV-1 infections in Slovenia (1986-2012) determined using an incidence algorithm

Journal of Medical Virology

Volumn 87, Issue 9, 2015, Pages 1510-1516

  Lunar, Maja M ^a   Matković, Ivana ^a   Tomažič, Janez ^b   Vovko, Tomaž D ^b   Pečavar, Blaž ^b   Poljak, Mario ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

BED EIA; HIV 1; Incidence; Surveillance

Indexed keywords

ACUTE RETROVIRAL SYNDROME; ADULT; AGE DISTRIBUTION; ALGORITHM; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; SLOVENIA; SYNDROME; TREND STUDY; VIRUS IDENTIFICATION; VIRUS LOAD; GENETICS; HEALTH SURVEY; HIV INFECTIONS; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; TIME FACTOR; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; ALGORITHMS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; SLOVENIA; TIME FACTORS; VIRAL LOAD;

EID: 84937073866     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24209     Document Type: Article

References (28)

1. Bätzing-Feigenbaum J, Loschen S, Gohlke-Micknis S, Zimmermann R, Herrmann A, Kamga Wambo O, Kücherer C, Hamouda O. 2008. Country- wide HIV incidence study complementing HIV surveillance in Germany. Euro Surveill 13:339-342.
2. Babič DZ, Poljak M, Seme K, Tomažič J, Vidmar L. 2006. Molecular epidemiology of HIV-1 subtypes based on analysis of pol sequences in Slovenia, 1996-2005. J Med Virol 78:997-1002.
3. Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH. 2013. Estimation of HIV incidence using multiple biomarkers. Am J Epidemiol 177:264-272.
4. Calypte Biomedical Corporation 2008. AwareTM BED TM EIA HIV-1 Incidence Test (IgG-Capture HIV-EIA) Package Insert. Available at: http://www.calypte.com/pdf/LN-20597%20A_%20Aware%20BED%20EIA%20HIV-1_2%20Incidence%20Test%20Package%20Insert.pdf.
5. Chaillon A, Le Vu S, Brunet S, Gras G, Bastides F, Bernard L, Meyer L, Barin F. 2012. Decreased specificity of an assay for recent infection in HIV-1-infected patients on highly active antiretroviral treatment: implications for incidence estimates. Clin Vaccine Immunol 19:1248-1253.
6. Cousins MM, Konikoff J, Laeyendecker O, Celum C, Buchbinder SP, Seage 3rd GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH. 2014. HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm. J Clin Microbiol 52:115-121.
7. Guy R, Gold J, Calleja JM, Kim AA, Parekh B, Busch M, Rehle T, Hargrove J, Remis RS, Kaldor JM, WHO Working Group on HIV Incidence Assays. 2009. Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. Lancet Infect Dis 9:747-759.
8. Hauser A, Santos-Hoevener C, Meixenberger K, Zimmermann R, Somogyi S, Fiedler S, Hofmann A, Bartmeyer B, Jansen K, Hamouda O, Bannert N, Kuecherer C. 2014. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort. PLoS ONE 9:e98038.
9. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP. 1998. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 280:42-48.
10. Klavs I, Bergant N, Kustec T, Kastelic Z. 2007. Okužba s HIV v Sloveniji, letno poročilo 2006. Ljubljana: Inštitut za varovanje zdravja RS. Available at http://www.ivz.si/hiv_spo?pi=5&_5_Filename=294.pdf&_5_MediaId=294&_5_AutoResize=false&pl=107-5.3.
11. Klavs I, Kustec T, Kastelic Z. 2013. Okužba s HIV v Sloveniji, letno poročilo 2012. Ljubljana: Inštitut za varovanje zdravja RS. Available at: http://www.ivz.si/hiv_spo?pi=5&_5_Filename=7306.pdf&_5_MediaId=7306&_5_AutoResize=false&pl=107-5.3.
12. Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, Seage 3rd GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Justman JE, Hodder SL, Quinn TC, Eshleman SH, Laeyendecker O. 2013. Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States. PLoS ONE 8:e82772.
13. Laeyendecker O, Brookmeyer R, Oliver AE, Mullis CE, Eaton KP, Mueller AC, Jacobson LP, Margolick JB, Brown J, Rinaldo CR, Quinn TC, Eshleman SH; Multicenter Aids Cohort Study Macs . 2012. Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. AIDS Res Hum Retroviruses 28:816-822.
14. Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage 3rd GR, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman SH. 2013. HIV incidence determination in the United States: A multiassay approach. J Infect Dis 207:232-239.
15. Laeyendecker O, Kulich M, Donnell D, Komárek A, Omelka M, Mullis CE, Szekeres G, Piwowar-Manning E, Fiamma A, Gray RH, Lutalo T, Morrison CS, Salata RA, Chipato T, Celum C, Kahle EM, Taha TE, Kumwenda NI, Karim QA, Naranbhai V, Lingappa JR, Sweat MD, Coates T, Eshleman SH. 2013b. Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial. PLoS ONE 8:e78818.
16. Lange JM, Paul DA, Huisman HG, de Wolf F, van den Berg H, Coutinho RA, Danner SA, van der Noordaa J, Goudsmit J. 1986. Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J 293:1459-1462.
17. Longosz AF, Serwadda D, Nalugoda F, Kigozi G, Franco V, Gray RH, Quinn TC, Eshleman SH, Laeyendecker O. 2014. Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda. AIDS Res Hum Retroviruses 30:339-344.
18. Lunar MM, Židovec Lepej S, Abecasis AB, Tomažič J, Vidmar L, Karner P, Vovko TD, Pečavar B, Maver P, Seme K, Poljak M. 2013. Short communication: prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005-2010. AIDS Res Hum Retroviruses 29:343-349.
19. Meixenberger K, Hauser A, Jansen K, Yousef KP, Fiedler S, von Kleist M, Norley S, Somogyi S, Hamouda O, Bannert N, Bartmeyer B, Kücherer C. 2014. Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies. J Clin Microbiol 52:2977-2983.
20. McDougal JS, Parekh BS, Peterson ML, Branson BM, Dobbs T, Ackers M, Gurwith M. 2006. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses 22:945-952.
21. Mullis CE, Munshaw S, Grabowski MK, Eshleman SH, Serwadda D, Brookmeyer R, Nalugoda F, Kigozi G, Kagaayi J, Tobian AA, Wawer M, Gray RH, Quinn TC, Laeyendecker O. 2013. Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda. AIDS Res Hum Retroviruses 29:1146-1150.
22. Murphy G, Parry JV. 2008. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill 13:314-320.
23. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, Hu DJ, Vanichseni S, Young NL, Choopanya K, Mastro TD, McDougal JS. 2002. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 18:295-307.
24. Pirš M, Poljak M, Seme K, Babič DZ, Tomažič J. 2006. Clinical features and virologic characteristics of primary and early HIV-1 infection in Slovenian patients. Coll Antropol 30:47-52.
25. Semaille C, Pillonel J, Lot F, Le Vu S, Pinget R, Desenclos JC, Barin F. 2008. Four years of surveillance of recent HIV infections at country level, France, mid 2003-2006: Experience and perspectives. Euro Surveill 13:327-332.
26. Stanojevic M, Alexiev I, Beshkov D, Gökengin D, Mezei M, Minarovits J, Otelea D, Paraschiv S, Poljak M, Židovec Lepej S, Paraskevis D. 2012. HIV-1 molecular epidemiology in the Balkans-a melting pot for high genetic diversity. AIDS Rev 14:28-36.
27. WHO. 2009. WHO Technical Working Group on HIV Incidence Assays: meeting report. Cape Town: South Africa. Available at: http://www.who.int/diagnostics_laboratory/links/hiviwg_capetown_07_09.pdf.
28. WHO. 2011. When and how to use assays for recent infection to estimate HIV incidence at a population level. Geneva: WHO. Available at: http://www.who.int/diagnostics_laboratory/110906_guidance:hiv_incidence.pdf.